Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Lifting the curtain on molecular differences between malignant pleural mesotheliomas

We introduce molecular and cellular criteria — based on morphology, ploidy, CpG island methylation and immune infiltration — that improve the characterization of malignant pleural mesothelioma. These criteria reveal adaptation strategies that are adopted by tumor cells and offer new possibilities for classification and clinical management.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: The utility of a four-criteria classification of mesothelioma.

References

  1. Van Zandwijk, N. et al. The silent malignant mesothelioma epidemic: a call to action. Lancet Oncol. 23, 1245–1248 (2022). A review article that describes the alarming dynamic of the mesothelioma epidemic.

    Article  Google Scholar 

  2. Argelaguet, R. et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. BMC Genome Biol. 21, 1–17 (2020). This paper presents a method to integrate multiple ‘omic’ layers to characterize inter-sample molecular variations.

    Google Scholar 

  3. Alcala, N. et al. Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions. Ebiomedicine 48, 191–202 (2019). This paper reports that rather than falling into distinct categories, mesotheliomas form a continuum of molecular types.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hausser, J. & Alon, U. Tumour heterogeneity and the evolutionary trade-offs of cancer. Nat. Rev. Cancer 20, 247–257 (2020). A review article that presents a framework to identify trade-offs between cancer tasks.

    Article  CAS  PubMed  Google Scholar 

  5. Di Genova, A. et al. A molecular phenotypic map of malignant pleural mesothelioma. GigaScience 12, giac128 (2023). This data note describes the sequencing data from the MESOMICS cohort and provides a molecular map integrating all major mesothelioma cohorts to date.

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Mangiante, L. et al. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat. Genet. https://doi.org/10.1038/s41588-023-01321-1 (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nat Genet 55, 540–541 (2023). https://doi.org/10.1038/s41588-023-01322-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-023-01322-0

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer